Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIntercept Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Intercept Pharmaceuticals, Inc. Earnings Date And Information
Intercept Pharmaceuticals, Inc. last posted its earnings results on Tuesday, November 7th, 2023. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.2. The company had revenue of 88.79 M for the quarter and had revenue of 285.71 M for the year. Intercept Pharmaceuticals, Inc. has generated $3 earnings per share over the last year ($3.4 diluted earnings per share) and currently has a price-to-earnings ratio of -91.78. Intercept Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 5th, 2023 based on prior year's report dates.
Intercept Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2023 | Q3 2023 | N/A | -$0.07 | N/A | $88.02 M | $88.79 M |
| 08/02/2023 | Q2 2023 | -$0.56 | -$0.14 | 0.42 | $79.57 M | $83.72 M |
| 04/27/2023 | Q1 2023 | -$0.57 | -$0.71 | -0.14 | N/A | $67.96 M |
| 03/02/2023 | Q4 2022 | -$0.53 | -$0.49 | 0.04 | N/A | $77.22 M |
| 11/01/2022 | Q3 2022 | $5.11 | $5.07 | -0.04 | $89.99 M | $77.59 M |
| 08/03/2022 | Q2 2022 | -$0.53 | -$0.25 | 0.28 | $95.72 M | $71.76 M |
| 05/06/2022 | Q1 2022 | -$0.89 | -$0.58 | 0.31 | N/A | $88.58 M |
| 03/02/2022 | Q4 2021 | -$1.26 | -$1.23 | 0.03 | N/A | $92.40 M |
| 11/03/2021 | Q3 2021 | -$1.00 | -$0.11 | 0.89 | $81.81 M | $92.83 M |
| 07/29/2021 | Q2 2021 | -$1.24 | -$0.33 | 0.91 | $82.68 M | $96.58 M |
| 05/06/2021 | Q1 2021 | -$1.53 | -$1.22 | 0.31 | N/A | $81.66 M |
| 02/25/2021 | Q4 2020 | -$1.55 | -$1.58 | -0.03 | N/A | $83.27 M |
| 11/09/2020 | Q3 2020 | -$1.96 | -$2.01 | -0.05 | $76.22 M | $79.52 M |
| 08/10/2020 | Q2 2020 | -$2.94 | -$1.92 | 1.02 | $117.48 M | $77.25 M |
| 05/11/2020 | Q1 2020 | -$2.94 | -$2.86 | 0.08 | N/A | $72.65 M |
| 02/25/2020 | Q4 2019 | -$2.56 | -$2.99 | -0.43 | N/A | $71.50 M |
| 11/05/2019 | Q3 2019 | -$2.35 | -$2.59 | -0.24 | $58.12 M | $61.95 M |
| 08/08/2019 | Q2 2019 | N/A | -$2.28 | N/A | $75.61 M | $66.30 M |
| 05/08/2019 | Q1 2019 | -$2.57 | -$3.03 | -0.46 | N/A | $52.25 M |
| 03/01/2019 | Q4 2018 | N/A | -$2.97 | N/A | N/A | $53.28 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intercept Pharmaceuticals, Inc. Earnings: FAQ's
Intercept Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 5th, 2023 based offlast year's report dates.
In the previous quarter, Intercept Pharmaceuticals, Inc. (:ICPT) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.2.
The conference call for Intercept Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Intercept Pharmaceuticals, Inc.'s latest earnings report can be read online.
Intercept Pharmaceuticals, Inc. (:ICPT) has a recorded annual revenue of $285.71 M.
Intercept Pharmaceuticals, Inc. (:ICPT) has a recorded net income of $115.17 M.Intercept Pharmaceuticals, Inc. has generated $3.41 earnings per share over the last four quarters.
Intercept Pharmaceuticals, Inc. (:ICPT) has a price-to-earnings ratio of -91.78 and price/earnings-to-growth ratio is 0.67.